IRIS
GANDAGLIA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.011
EU - Europa 4.150
NA - Nord America 3.722
SA - Sud America 2.408
AF - Africa 147
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 17.453
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.536
SG - Singapore 2.915
BR - Brasile 2.015
CN - Cina 1.650
IT - Italia 1.637
HK - Hong Kong 1.176
SE - Svezia 1.033
VN - Vietnam 673
RU - Federazione Russa 422
DE - Germania 242
AR - Argentina 189
FI - Finlandia 150
NL - Olanda 133
JP - Giappone 124
GB - Regno Unito 109
IN - India 90
CA - Canada 83
FR - Francia 76
TR - Turchia 71
IE - Irlanda 70
BD - Bangladesh 67
EC - Ecuador 58
MX - Messico 58
AT - Austria 57
CO - Colombia 56
PL - Polonia 56
ID - Indonesia 55
ZA - Sudafrica 53
IQ - Iraq 41
ES - Italia 40
MA - Marocco 38
PK - Pakistan 23
PY - Paraguay 23
VE - Venezuela 21
UA - Ucraina 20
LT - Lituania 19
SA - Arabia Saudita 17
UZ - Uzbekistan 16
CL - Cile 15
EG - Egitto 15
PE - Perù 14
CZ - Repubblica Ceca 13
AE - Emirati Arabi Uniti 12
DO - Repubblica Dominicana 12
TN - Tunisia 12
UY - Uruguay 11
DZ - Algeria 10
NP - Nepal 9
BG - Bulgaria 8
KE - Kenya 8
PT - Portogallo 8
AU - Australia 7
BE - Belgio 7
CH - Svizzera 7
IR - Iran 7
MY - Malesia 7
NO - Norvegia 7
AZ - Azerbaigian 6
DK - Danimarca 6
IL - Israele 6
JO - Giordania 6
KR - Corea 6
BO - Bolivia 5
CR - Costa Rica 5
HN - Honduras 5
KZ - Kazakistan 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BH - Bahrain 4
GT - Guatemala 4
HU - Ungheria 4
PA - Panama 4
AL - Albania 3
ET - Etiopia 3
GR - Grecia 3
JM - Giamaica 3
KG - Kirghizistan 3
NZ - Nuova Zelanda 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BN - Brunei Darussalam 2
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
EU - Europa 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BJ - Benin 1
Totale 17.437
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.172
Singapore 1.137
Dallas 768
Shanghai 462
Hefei 440
Lawrence 412
Princeton 408
Ashburn 400
Milan 363
Ho Chi Minh City 254
Moscow 180
Beijing 179
New York 179
São Paulo 158
Hanoi 143
Rome 119
Los Angeles 106
Helsinki 105
Dublin 69
Rio de Janeiro 68
Munich 61
Nuremberg 58
Boardman 49
Turin 49
Tokyo 43
Warsaw 43
Belo Horizonte 39
Brooklyn 36
Montreal 34
Brasília 33
Florence 33
Porto Alegre 33
Curitiba 32
Santa Clara 32
Turku 31
Bologna 30
Chicago 28
Da Nang 28
Haiphong 28
Verona 27
Stockholm 26
Vienna 26
Guangzhou 25
Biên Hòa 24
Salvador 24
Atlanta 23
Chennai 23
Genoa 23
Johannesburg 23
Denver 22
Guayaquil 22
Ankara 21
Brescia 21
Naples 21
Palermo 21
Phoenix 21
The Dalles 21
Buenos Aires 20
London 20
Boston 19
Campinas 19
Columbus 19
Fortaleza 19
Goiânia 19
Manaus 19
Pune 19
Thái Bình 19
Toronto 18
Bari 17
Houston 17
Poplar 17
San Francisco 17
Seattle 17
Betim 16
Council Bluffs 16
Manchester 15
Orem 15
Borås 14
Caxias do Sul 14
Juiz de Fora 14
Mexico City 14
Ninh Bình 14
Paris 14
Washington 14
Maceió 13
Osasco 13
St Petersburg 13
Sumaré 13
Tashkent 13
Baghdad 12
Bauru 12
Cesano Boscone 12
Frankfurt am Main 12
Guarulhos 12
Quito 12
Recife 12
Ribeirão Preto 12
Santo André 12
Tianjin 12
Azzano San Paolo 11
Totale 8.907
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.614
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 161
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 107
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 100
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 99
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 99
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 98
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 92
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 89
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 89
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 88
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 75
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 74
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 73
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 72
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 71
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 71
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 70
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 70
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 70
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 70
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 69
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 68
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 67
A Novel Classification Proposal for Rectourethral Fistulas After Primary Treatment of Prostate Cancer 65
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 65
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 65
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 65
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 64
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 64
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 63
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer 63
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer 62
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 62
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 61
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 61
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 61
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 61
A detailed analysis of the association between postoperative phosphodiesterase type 5 inhibitor use and the risk of biochemical recurrence after radical prostatectomy 59
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 59
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 59
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 58
Assessing the Impact of Surgeon Experience on Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons 58
Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma 58
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research 58
Reply by Authors 58
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent 58
A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis 56
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 56
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the International Staging Collaboration for Cancer of the Prostate 56
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 55
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 55
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 55
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 55
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 55
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 54
"Trifecta' outcomes of robot-assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis 54
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 54
A novel tool for the prediction of urinary incontinence after bilateral nerve-sparing radical prostatectomy 53
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 53
A NOVEL TOOL FOR THE PREDICTION OF URINARY INCONTINENCE AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 52
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 52
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series 52
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 51
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 51
Improving the stratification of intermediate risk prostate cancer 51
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer 51
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 51
Introducing PIONEER: a project to harness big data in prostate cancer research 50
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy 49
The Importance of an Adequate Surgical Template During Salvage Lymph Node Dissection for Node-Recurrent Prostate Cancer 49
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 49
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 49
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 48
Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study). 48
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 48
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis 47
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study 47
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 47
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x) 47
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 47
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 47
Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database 46
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer 46
Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up 45
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 45
RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates 45
A systematic review of the association between erectile dysfunction and cardiovascular disease 44
Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy 44
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review 44
IMPATTO DELLA CLIMACTURIA SULLA FUNZIONE ORGASMICA IN PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE RETROPUBICA NERVE SPARING BILATERALE 43
Re: Sophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.012: Surgical Treatment of Local Recurrence Following Radical Prostatectomy: Reality or Illusion? 43
Technical and Functional Validation of a Teleoperated Multirobots Platform for Minimally Invasive Surgery 42
Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy 42
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate 42
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 41
Cytotoxic Chemotherapy and Targeted Agents 41
Totale 7.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.991
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 45 1 1 5 6 0 0
2021/2022364 0 48 39 116 13 19 31 24 10 14 21 29
2022/20232.140 964 443 116 26 15 230 91 136 59 8 28 24
2023/20241.237 24 48 106 92 89 214 116 126 16 110 122 174
2024/20256.038 829 157 149 140 174 496 722 500 1.105 887 407 472
2025/20267.839 1.213 1.445 1.359 2.567 1.190 65 0 0 0 0 0 0
Totale 17.904